Literatur

• Literatur

• 1 Althage MC. et al. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem 2008; 283 (26) 18365-76.
• 2 Asmar M, Holst JJ. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes 2010; 17: 57-62.
• 3 Baptista T. et al. Antipsychotic drugs and obesity: is prolactin involved?. Can J Psychiatry 2001; 46: 829-834.
• 4 Blüher S. et al. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab 2005; 19: 577-587.
• 5 Blum JW, Baumrucker CR. Insulin-like growth factors (IGFs), IGF binding proteins, and other endocrine factors in milk: role in the newborn. In: Bösze Z. Bioactive components of milk. Advances in experimental medicine and biology, Vol. 606. New York: Springer; 2008: 397-422.
• 6 Brandebourg T. et al. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obesity Metabol 2007; 09: 464-476.
• 7 Bounous G. et al. Evolutionary traits in human milk proteins. Med Hypotheses 1988; 27: 133-140.
• 8 Calbet JAL, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr 2004; 43: 127-139.
• 9 Choi S. et al. Meal ingestion, amino acids and brain neurotransmitters: effects of dietary protein source on serotonin and catecholamine synthesis rates. Physiol Behav 2009; 98: 156-162.
• 10 Crowe FL. et al. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2009; 18: 1333-1340.
• 11 Doknic M. et al. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 2002; 147: 77-84.
• 12 Farmer SR. The forkhead transcription factor Foxo1: a possible link between obesity and insulin resistance. Mol Cell 2003; 11: 6-8.
• 13 Flatt PR. Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes?. Diabetic Medicine 2008; 25: 759-764.
• 14 Fleenor D. et al. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res 2006; 66: 101-110.
• 15 Freeman ME. et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-1631.
• 16 Gahete MD. et al. Understanding the multifactorial control of growth hormone release by somatotropes. Lessons from comparative endocrinology. Trends in Comp Endocrinol Neurobiol : Ann NY Acad Sci 2009; 1163: 137-153.
• 17 Gerin I. et al. On the role of FOXO transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake. J Biol Chem 2009; 284: 10755-10763.
• 18 Getty-Kaishik L. et al. Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity 2006; 14: 1124-1131.
• 19 Greenman Y. et al. Increased body weight associated with prolactin secreting pituitary adenomas: weigth loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 1998; 48: 547-553.
• 20 Gresti J. et al. Composition of molecular species of triacylglycerols in bovine milk fat. J Dairy Sci 1993; 76: 1850-1869.
• 21 Gross DN. et al. The role of FoxO in the regulation of metabolism. Oncogene 2008; 27: 2320-2336.
• 22 Gunnarsson PT. et al. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 2006; 147: 3173-3180.
• 23 Holt S. et al. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr 1997; 66: 1264-1267.
• 24 Hoyt G. et al. Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr 2005; 93: 175-157.
• 25 Irwin N, Flatt PR. Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-realted diabetes and possible therapeutic implications. Diabetologia 2009; 52: 1724-1731.
• 26 Kawai M. et al. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J Mol Endocrinol 2007; 38: 19-34.
• 27 Kelly KR. et al. The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am J Physiol Endocrinol Metab 2009; 296: E1269-E1274.
• 28 Kiess W. et al. Adipocytes and adipose tissue. Best Practice Res Clin Endocrinol Metabol 2008; 22: 135-153.
• 29 Kim JJ. et al. FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue. Diabetes 2009; 58: 1275-1282.
• 30 Kim SJ. et al. Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem 2007; 282: 8557-8567.
• 31 Kim SJ. et al. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J Biol Chem 2007; 282: 34139-341347.
• 32 Koletzko B. et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr 2009; 89: 1836-1845.
• 33 Krulich L. Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Ann Rev Physiol 1979; 41: 603-615.
• 34 Lien EL. Infant formulas with increased concentrations of α-lactalbumin. Am J Clin Nutr 2003; 77 (Suppl): 1555S-1558S.
• 35 Liljeberg EH, Bjorck I. Milk as a supplement to mixed meals may elevate postprandial insulinaemia. Eur J Clin Nutr 2001; 55: 994-999.
• 36 Lönnerdal B. Personalizing nutrient intakes of formula-fed Infants: Breast milk as a model. Nestlé Nutr Workshop Ser Pediatr Program 2008; 62: 189-203.
• 37 Lu C. et al. A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation. Endocrinology 2010; 151: 2189-2199.
• 38 Lucas A. et al. Breast vs bottle: endocrine responses are different with formula feeding. Lancet 1980; 01: 1267-1269.
• 39 Lucas A. et al. Metabolic and endocrine responses to a milk feed in six-day-old term infants: differences between breast and cow´s milk formula feeding. Acta Paediatr Scand 1981; 70: 195-200.
• 40 Lucey MR. et al. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man. Clin Endocrinol 1984; 21: 209-217.
• 41 Magun R. et al. Expression of a constitutively activated form of protein kinase B(c-Akt) in 3T3-l1 preadipose cells causes spontaneous differentiation. Endocrinologiy 1996; 137: 3590-3593.
• 42 Markus CR. Dietary amino acids and brain serotonin function; implications for stress-related affective changes. Neuromol Med 2008; 10: 247-258.
• 43 McIntosh CHS. et al. Glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide; GIP) Vit Horm. 2009; 80: 409-471.
• 44 Melnik BC, Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol 2009; 18: 833-841.
• 45 Melnik BC. Milk – the promoter of chronic Western diseases. Med Hypotheses 2009; 72: 631-639.
• 46 Melnik B. Acne vulgaris: Rolle der Diät. Hautarzt 2010; 61: 115-125.
• 47 Melnik BC. FoxO1 – the key for the pathogenesis and therapy of acne?. J Dtsch Dermatol Ges 2010; 08: 105-114.
• 48 Mingrone G. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis 2008; 18: 574-579.
• 49 Miyawaki K. et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002; 08: 738-742.
• 50 Morgan LM. The metabolic role of GIP: physiology and pathology. Biochem Soc Trans 1996; 24 (02) 585-591.
• 51 Muruganandan S. et al. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells. Cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009; 66: 236-253.
• 52 Naitoh R. et al. Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice. Biochem Biophys Res Commun 2008; 376: 21-25.
• 53 Nakae J. et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003; 04: 119-129.
• 54 Nanbu-Wakao R. et al. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 2000; 14: 307-316.
• 55 Nilsson M. et al. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 2007; 85: 996-1004.
• 56 Norat T. et al. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 2007; 61: 91-98.
• 57 Rich-Edwards JW. et al. Milk consumption and the prepubertal somatotropic axis. Nutr J 2007; 06: 28.
• 58 Smith PJ. et al. Insulin-like growth factor I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 1988; 263: 9402-9408.
• 59 Song DH. et al. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Gastroenterology 2007; 133: 1796-1805.
• 60 Starich GH. et al. GIP increases insulin receptor affinity and cellular sensitivity in adipocytes. Am J Physiol 1985; 249: E603-E607.
• 61 Stewart WC. et al. Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: coordinate regulation of STATs 1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma and C/AAAT enhancer binding protein-alpha. Biochim Biophys Acta 1999; 1452: 188-196.
• 62 Stewart WC. et al. STAT5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cell. Biochem Biophys Res Commun 2004; 324: 355-359.
• 63 Thomsen C. et al. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 1999; 69: 1135-1143.
• 64 van Vught AJ. et al. The effects of dietary protein on the somatotropic axis: a comparison of soy, gelatin, alpha-lactalbumin and milk. Eur J Clin Nutr 2010; 64: 441-446.
• 65 Vilsbøll T. et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 2003; 88: 2706-2713.
• 66 Wabitsch M. et al. The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism 1995; 44: 45-49.
• 67 Wiley AS. Dairy and milk consumption and child growth: Is BMI involved? An analysis of NHANES 1999–2004. Am J Hum Biol 2010; 22: 517-525.
• 68 Wurtman RJ. et al. Precursor control of neurotransmitter synthesis. Pharmacol Rev 1981; 32: 315-335.
• 69 Yip RGC, Wolfe MM. GIP biology and fat metabolism. Life Sci 2000; 66: 91-103.